Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

SVF injection into wrist

Phase 2Small molecule

UUniversity Hospital, Rouen

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

RhizarthrosisRecruiting

RhizarthrosisPhase 2

Recruiting

Timeline

Expected Milestones

Q4 2026

Phase 2Recruiting

Rhizarthrosis

NCT05708430

Clinical

Trials by Indication[1]

Rhizarthrosis1 trial

Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis

Recruiting·UUniversity Hospital, Rouen·Phase 2·NCT05708430·12 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for SVF injection into wrist. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — SVF injection into wrist compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for SVF injection into wrist. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Rouen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity Hospital, Rouen

Related News